Medical policy

Displaying 71 - 80 of 101

2025 portable X-ray response to comments

Thank you for taking the time to provide your comments on portable x-ray services. First Coast appreciates your feedback and your engagement in this important discussion. 

Billing for Rebyota fecal microbiota, live-jslm, HCPCS code J1440 -- Avoid rejections

Previous instructions to bill Rebyota fecal microbiota, live-jslm with HCPCS G0455, expired effective June 30, 2023. Instead, providers shall bill HCPCS code J1440 on the same claim with HCPCS 0780T…

Billing for Rebyota fecal microbiota, live-jslm, HCPCS code J1440 -- Avoid rejections

Previous instructions to bill Rebyota fecal microbiota, live-jslm with HCPCS G0455, expired effective June 30, 2023. Instead, providers shall bill HCPCS code J1440 on the same claim with HCPCS 0780T…

Reporting the national drug code

Read this article for helpful information to report the national drug code on claims.

No Medicare policies identified

In the absence of a LCD, NCD, billing and coding article or CMS manual instruction, NCCI or MUE, reasonable and necessary guidelines still apply. Read this article to learn more.

No Medicare policies identified

In the absence of a LCD, NCD, billing and coding article or CMS manual instruction, NCCI or MUE, reasonable and necessary guidelines still apply. Read this article to learn more.

Document and bill genetic tests correctly

First Coast identified several errors when providers bill for genetic testing. Read this article to learn more about billing these services correctly.

Understanding clinical trials and device coverage

Clinical trials background What regulatory guidance addresses devices and clinical trials in the Medicare program? 

Understanding clinical trials and device coverage

Clinical trials background What regulatory guidance addresses devices and clinical trials in the Medicare program? 

Additional frequently asked questions about clinical trials and device coverage

View these additional FAQs about clinical trials and device coverage.